Quaternized chitosan-coated liposomes enhance immune responses by co-delivery of antigens and resveratrol

Int J Pharm. 2022 Nov 25:628:122277. doi: 10.1016/j.ijpharm.2022.122277. Epub 2022 Oct 12.

Abstract

Co-localization of antigens and immunomodulators in the same antigen-presenting cells (APCs) can powerfully activate APCs and enhance immune responses. In this study, the immunomodulator resveratrol (Res) was encapsulated into quaternized chitosan (QCS) - coated liposomes for developing a new nanoparticle delivery system (QCS-Res-LP), and ovalbumin (OVA) was selected as a model antigen and adsorbed on the surface of QCS-Res-LP. The results showed that the particle size of QCS-Res-LP was 96.3 ± 3.52 nm; the PDI value was 0.280 ± 0.010; the Zeta potential was 9.59 ± 0.36 mV. QCS-Res-LP could encapsulate 76.22 ± 1.02 % resveratrol and adsorb 88.2 ± 16.3 % antigen. QCS-Res-LP effectively promoted the co-uptake of antigen and Res by dendritic cells (DCs) with 50-fold greater than resveratrol liposomes (Res-LP). QCS-Res-LP promoted expression levels of CD80, CD86, IL-2, and IL-12 in DCs. QCS-Res-LP did not cause hemolysis. The levels of ovalbumin-specific IgG antibodies and cytokines were significantly increased in mice vaccinated with ovalbumin-absorbed QCS-Res-LP, which induced a mixed Th1/Th2 immune response. In conclusion, these results demonstrated that QCS-coated liposomes enable the co-delivery of antigens and immunomodulators to induce strong and durable immune responses.

Keywords: Cellular uptake; Co-delivery; Immune response; Liposomes; Quaternized chitosan; Resveratrol.

MeSH terms

  • Adjuvants, Immunologic
  • Animals
  • Antigens
  • Chitosan* / metabolism
  • Dendritic Cells
  • Immunity
  • Liposomes* / metabolism
  • Mice
  • Ovalbumin
  • Resveratrol

Substances

  • Liposomes
  • Chitosan
  • Resveratrol
  • Ovalbumin
  • Antigens
  • Adjuvants, Immunologic